Oncor Pharmaceuticals
4 drugs in NADAC|4 Generic,0 Brand
Oncor Pharmaceuticals lists 4 NDCs in the CMS NADAC file (4 generic, 0 brand), at an average NADAC of $0.13 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
4G / 0B
Avg Price / Unit
$0.1323
$0.01 – $0.49
Avg 7d Change
-0.24%
Across 4 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Lidocaine 4% market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Amide Local Anesthetic therapeutic class
Review the broader class where Oncor Pharmaceuticals has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Oncor Pharmaceuticals make?
Oncor Pharmaceuticals lists 4 NDCs in the CMS NADAC file — 4 generic and 0 brand products.
What is the average price of Oncor Pharmaceuticals drugs?
The average NADAC across Oncor Pharmaceuticals's portfolio is $0.1323 per unit, ranging from $0.0107 to $0.4899.
What types of drugs does Oncor Pharmaceuticals make?
Oncor Pharmaceuticals makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Amide Local Anesthetic (1), Antiarrhythmic (1), Histamine-1 Receptor Antagonist (1), Expectorant (1).
Has Oncor Pharmaceuticals had any drug recalls?
No FDA enforcement recalls are matched to Oncor Pharmaceuticals in the openFDA feed.
How has Oncor Pharmaceuticals's pricing changed recently?
Over the past 7 days, 1 Oncor Pharmaceuticals product rose and 3 fell, with a portfolio-wide average change of -0.2%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LIDOCAINE 4% CREAM Lidocaine 4% | $0.4899 per GM | +1.54% |
DIPHENHYDRAMINE 12.5 MG/5 ML Diphenhydramine Hydrochloride | $0.0174 per ML | -0.40% |
GUAIFENESIN 100 MG/5 ML SOLN Guaifenesin | $0.0110 per ML | -1.25% |
CHILD PAIN-FEVER 160 MG/5 ML Acetaminophen | $0.0107 per ML | -0.84% |